In summary, we found that CTLL-2 cells undergo ER stress that causes cell depletion through the PERK-CHOP pathway, and ER stress and restoration of cell functions can be partly reversed by adding TP, which provides a potential new therapeutic approach to treat liver cancer. The gene discussed is EIF2AK3; the disease is liver cancer.